Johnson & Johnson shares jump after UBS raises target to $320
Johnson & Johnson surged roughly 1.2% to $274.395 as UBS raised its price target from $280 to $320, with Barron's reporting the stock became a top Dow point contributor in early trading.
Johnson & Johnson NYSE:JNJ rose roughly 1.2% to $274.395 on Wednesday after UBS lifted its price target to $320 from $280. Barron's said J&J was the Dow's biggest point booster in early trading.